Despite the sharp intraday loss, the stock has risen 23% so far in 2025. 
Despite the sharp intraday loss, the stock has risen 23% so far in 2025. Shares of Yatharth Hospital and Trauma Care Services Ltd. declined over 9% on Friday, following a significant block deal in which promoter Neena Tyagi offloaded 5.85% stake or 56.33 lakh shares at Rs 716.73 apiece for Rs 403.93 crore. Tyagi owned 6.47% stake or 62.32 lakh shares in the hospital firm at the end of September 2025 quarter. Kotak Mutual Fund and Carnelian Asset Management & Advisors Private Limited were the buyers in the block deal. .
The stock fell 9.58% to Rs 697 in the current session against the previous close of Rs 770.85.
Despite the sharp intraday loss, the stock has risen 23% so far in 2025. Trading volume was notably high for the session. The decline comes after news in Mid November that authorities had previously attached various properties and equity shares in three subsidiaries, which triggered concerns in the market.
In response to these developments, Ambit stated: "The recent move by authorities to attach various properties and equity shares in three subsidiaries raises concerns. Given our inability to assess the potential outcome or impact, we are dropping coverage on the stock," Ambit wrote in its note back then.
Regulatory matters have weighed on Yatharth Hospital's market standing, with the company having experienced income tax raids in October 2023. On November 13, the Deputy Commissioner of Income Tax, Delhi, issued orders for the release of all provisionally attached properties and unfreezing of all previously attached fixed deposits.
Yatharth Hospital commented on the situation, stating: "We have actively cooperated with the authorities and provided all the required information," Yatharth Hopitals said, adding that concerned authorities will be informed once the tax department concludes its investigation.
Brokerages such as Ambit had dropped coverage on the stock, citing ongoing investigations as a reason for concern. The outcome of the regulatory process remains an important factor for market participants monitoring the company's prospects.